Romano Brothers And Company Pet Iq, Inc. Transaction History

Romano Brothers And Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$17.18 - $22.38 $305,804 - $398,364	17,800 New	17,800 $351,000
Q3 2023 Oct 17, 2023	BUY	$15.0 - $20.71 $267,000 - $368,638	17,800 New	17,800 $350,000
Q2 2023 Jul 12, 2023	SELL	$10.84 - $15.43 $54,200 - $77,150	-5,000 Reduced 21.93%	17,800 $270,000
Q1 2023 Apr 13, 2023	SELL	$9.32 - $12.58 $18,640 - $25,160	-2,000 Reduced 8.06%	22,800 $260,000
Q4 2022 Jan 17, 2023	BUY	$6.82 - $12.07 $13,640 - $24,140	2,000 Added 8.77%	24,800 $0
Q3 2022 Oct 18, 2022	BUY	$6.9 - $18.16 $157,320 - $414,048	22,800 New	22,800 $157,000

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Romano Brothers And Company, based on Form 13F filings with the SEC.

Stay updated on Romano Brothers And Company with notifications on news.